These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35703773)

  • 1. The Setting-Intervention Fit of Nine Evidence-Based Interventions for Substance Use Disorders Within HIV Service Organizations Across the United States: Results of a National Stakeholder-Engaged Real-Time Delphi Study.
    Garner BR; Knudsen HK; Zulkiewicz BA; Tueller SJ; Gotham HJ; Martin EG; Donohoe T; Toro AK; Loyd K; Gordon T
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S206-S214. PubMed ID: 35703773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence and Negative Impacts of Substance Use Disorders among People with HIV in the United States: A Real-Time Delphi Survey of Key Stakeholders.
    Garner BR; Gotham HJ; Knudsen HK; Zulkiewicz BA; Tueller SJ; Berzofsky M; Donohoe T; Martin EG; Brown LL; Gordon T
    AIDS Behav; 2022 Apr; 26(4):1183-1196. PubMed ID: 34586532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.
    Ray LA; Meredith LR; Kiluk BD; Walthers J; Carroll KM; Magill M
    JAMA Netw Open; 2020 Jun; 3(6):e208279. PubMed ID: 32558914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
    JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial.
    Garner BR; Gotham HJ; Tueller SJ; Ball EL; Kaiser D; Stilen P; Speck K; Vandersloot D; Rieckmann TR; Chaple M; Martin EG; Martino S
    Addict Sci Clin Pract; 2017 Nov; 12(1):31. PubMed ID: 29149914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics associated with the availability of therapeutic acupuncture in substance use disorder treatment facilities in the United States.
    Qeadan F; Madden EF; Barbeau WA; Kroth PJ; Porucznik CA; English K; Komaromy M; Sulzer SH
    J Addict Dis; 2023; 41(1):41-52. PubMed ID: 35343390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic.
    Wakeman SE; McGovern S; Kehoe L; Kane MT; Powell EA; Casey SK; Yacorps GM; Irvin JR; Rodriguez W; Regan S
    J Subst Abuse Treat; 2022 Oct; 141():108848. PubMed ID: 35926256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial for aggression and substance use involvement among Veterans: Impact of combining Motivational Interviewing, Cognitive Behavioral Treatment and telephone-based Continuing Care.
    Chermack ST; Bonar EE; Goldstick JE; Winters J; Blow FC; Friday S; Ilgen MA; Rauch SAM; Perron BE; Ngo QM; Walton MA
    J Subst Abuse Treat; 2019 Mar; 98():78-88. PubMed ID: 30665608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.
    Kraemer KL; McGinnis KA; Fiellin DA; Skanderson M; Gordon AJ; Robbins J; Zickmund S; Bryant K; Korthuis PT
    J Subst Abuse Treat; 2019 Aug; 103():23-32. PubMed ID: 31229189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Delphi Process to Prioritize an Agenda for Care Transition Research for Patients With Substance Use Disorders.
    Incze MA; Huebler S; Grant S; Gordon AJ
    Subst Use Addctn J; 2024 Jul; 45(3):523-528. PubMed ID: 38622904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.
    Wiercigroch D; Sheikh H; Hulme J
    Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):4. PubMed ID: 31931831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities.
    Ramdin C; Attaalla K; Ghafoor N; Nelson L
    J Addict Med; 2023 Mar-Apr 01; 17(2):e72-e77. PubMed ID: 35972137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors.
    Knudsen HK; Ducharme LJ; Roman PM
    J Subst Abuse Treat; 2006 Jun; 30(4):363-73. PubMed ID: 16716852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.
    Englander H; Dobbertin K; Lind BK; Nicolaidis C; Graven P; Dorfman C; Korthuis PT
    J Gen Intern Med; 2019 Dec; 34(12):2796-2803. PubMed ID: 31410816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorders among older adults: A review of randomized controlled pharmacotherapy trials.
    Tampi RR; Chhatlani A; Ahmad H; Balaram K; Dey J; Escobar R; Lingamchetty T
    World J Psychiatry; 2019 Sep; 9(5):78-82. PubMed ID: 31559148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection.
    Walley AY; Palmisano J; Sorensen-Alawad A; Chaisson C; Raj A; Samet JH; Drainoni ML
    J Subst Abuse Treat; 2015 Dec; 59():59-66. PubMed ID: 26298399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.
    Denis CM; Morales KH; Wu Q; Metzger DS; Cheatle MD
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 2(2):S142-S147. PubMed ID: 31658202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.